-
2020-12-08
优锐医药完成D轮融资
资金将支持正在进行的产品研发以及下一阶段的业务发展
-
2020-11-03
优锐医药5,300万美元引进Neumentum公司NTM-001镇痛药中国区权益
优锐医药将支付300万美元的预付款，后续最高将支付5,000万美元的额外潜在研发，监管和销售里程碑付款
-
2020-10-21
Neumentum and Nuance Biotech Enter into Licensing Agreement for NTM-001 (ketorolac for IV infusion) in China
Neumentum Inc. announced that the company has entered into a license agreement with Nuance Biotech Co. Ltd providing Nuance with the exclusive rights to develop and commercialize Neumentum's novel ketorolac for IV infusion (NTM-001) in China.
- 1
Contact PR
